Titan Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020, to consider and approve Audited Standalone and Consolidated Financial Results for financial year ended 31st March, 2020 and to consider recommendation of Final dividend for the financial year ended 31st March, 2020. The ‘Trading Window’ as per SEBI (Prohibition of Insider Trading) Regulations 2015 for dealing in securities of the Company by designated persons will be closed from 20th June, 2020 to 2nd July, 2020.
The above information is a part of company’s filings submitted to BSE.
